Arbios Biotech and the Lheidli T’enneh First Nation Announce Name for Groundbreaking Renewable Biofuels Facility
VANCOUVER, BC – Arbios Biotech (Arbios), and the Lheidli T’enneh First Nation are pleased to announce the naming of the Arbios commercial scale facility in Prince George, British Columbia, which is now known as Arbios Biotech Chuntoh Ghuna and means “The Forest Lives.” The Lheidli T’enneh First Nation and Arbios Biotech have been working in close partnership to develop the renewable biofuels facility, including the site preparation. The facility is located on the unceded and traditional territory of the Lheidli T’enneh.
“Having a plant name in Lheidli T’enneh’s dialect, Dakelh, has great significance for our Nation members” said Chief Dolleen Logan of the Lheidli T’enneh First Nation. “It demonstrates an observance of our ancestral lands and culture, and shows that it is possible for Indigenous communities and industry to work in harmony towards environmentally sound and mutually beneficial objectives. We are excited to be involved in a project that aligns with our environmental goals.”
A phased approach is being taken for the development of Arbios Biotech Chuntoh Ghuna, which will initially consist of one processing line. The facility will use the innovative Cat-HTR process to convert 25,000 dry tonnes of woody biomass including sawmill wood residue into 50,000 barrels of sustainable bio-oil per year, producing a direct substitute for fossil crude.
“We are honoured and delighted that the Lheidli T’enneh First Nation have named our first commercial scale facility,” said Alan Nicholl, President and CEO, Arbios Biotech. “We are pleased with the support and collaborative approach the Nation has taken with respect to this project. We look forward to continuing to work together as we strategically use our resources to bridge to a lower carbon future and use advanced technology to drive higher environmental and economic value from lower value residues.”
As an important step towards increasing the availability of low-carbon transportation fuels, the project is receiving strong support from both federal and provincial government programs, including receiving credits under BC’s Greenhouse Gas Reduction (Renewable and Low Carbon Fuel Requirements) Act; funding from Sustainable Development Technology Canada; the BC Ministry of Energy and Mines and Low Carbon Innovation’s Innovative Clean Energy Fund; and the Department of Natural Resources Canada’s Clean Growth Program.
About Arbios Biotech
Arbios Biotech is a joint venture between technology pioneers Licella Holdings Ltd (Licella) and integrated forest products company Canadian Forest Products Ltd. (Canfor). Arbios Biotech uses cutting edge technology to convert end-of-life wood and biomass into renewable biofuels and biochemicals. Licella is a global leader in the field of Hydrothermal Liquefaction (HTL). The company has dedicated over a decade to developing its patented Cat-HTR™ ('Catalytic Hydrothermal Reactor') platform that produces low-carbon biocrude (a renewable and sustainable bio-oil for the circular economy), from which low-carbon transportation fuels and chemicals can be produced. Canfor is one of the world’s largest producers of sustainable lumber, pulp and paper, and is a North American leader in green energy production. Arbios Biotech represents two leaders coming together with a shared vision - to create a low-carbon circular economy.
For more information, please visit www.arbiosbiotech.com
Forward Looking Statements
Certain statements in this press release constitute “forward-looking statements” which involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. Words such as “expects”, “anticipates”, “projects”, “intends”, “plans”, “will”, “believes”, “seeks”, “estimates”, “should”, “may”, “could”, and variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are based on management’s current expectations and beliefs and actual events or results may differ materially. There are many factors that could cause such actual events or results expressed or implied by such forward-looking statements to differ materially from any future results expressed or implied by such statements. Forward-looking statements are based on current expectations and Arbios assumes no obligation to update such information to reflect later events or developments, except as required by law.
Source: Arbios Biotech